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Abstract
Objectives: To determine the prevalence of sexually transmitted infections (STIs) and other
reproductive tract infections (RTIs) among pregnant women in Moshi, Tanzania and to compare
the occurrence of STIs/RTIs among human immunodeficiency virus (HIV)-infected and uninfected
women.
Methods: Pregnant women in their 3rd trimester (N = 2654) were recruited from two primary
health care clinics between June 2002 and March 2004. They were interviewed, examined and
genital and blood samples were collected for diagnosis of STIs/RTIs and HIV.
Results: The prevalence of HIV, active syphilis and herpes simplex virus – type 2 (HSV-2) were
6.9%, 0.9% and 33.6%, respectively, while 0.5% were positive for N gonorrhoeae, 5.0% for T vaginalis
and 20.9% for bacterial vaginosis. Genital tract infections were more prevalent in HIV-seropositive
than seronegative women, statistically significant for syphilis (3.3% vs 0.7%), HSV-2 (43.2% vs
32.0%), genital ulcers (4.4% vs 1.4%) and bacterial vaginosis (37.2% vs 19.6%). In comparison with
published data, a declining trend for curable STIs/RTIs (syphilis, trichomoniasis and bacterial
vaginosis) was noted.
Conclusion: Rates of STIs and RTIs are still high among pregnant women in Moshi. Where
resources allow, routine screening and treatment of STIs/RTIs in the antenatal care setting should
be offered. Higher STIs/RTIs in HIV-seropositive women supports the expansion of HIV-counseling
and testing services to all centers offering antenatal care. After identification, STIs/RTIs need to be
aggressively addressed in HIV-seropositive women, both at antenatal and antiretroviral therapy
care clinics.
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Sexually transmitted infections (STIs) are a major public
health problem, especially in developing countries [1,2].
They are highly prevalent among pregnant women in
Africa and cause significant maternal and perinatal mor-
bidity [2-6]. STIs and other reproductive tract infections
(RTIs) have been associated with a number of adverse
pregnancy outcomes including abortion, stillbirth, pre-
term delivery, low birth weight, postpartum sepsis, neona-
tal pneumonia, neonatal blindness & congenital infection
[1-4]. In addition, STIs/RTIs have been shown to facilitate
transmission of HIV [7-12]. The control of STIs/RTIs,
especially in pregnancy, is thus a priority, particularly in
resource-poor settings where they are prevalent.
The prevalence of STIs however, has been shown to vary
from one country to another and among different groups
within the same country [2]. In Tanzania, the difference of
STI/RTI prevalence by region, population and time-period
has been observed [3,6,13-18]. There is thus a need to
have local knowledge of the epidemiology of STIs/RTIs by
periodically monitoring the prevalence of etiological
agents. This information is useful in guiding clinical man-
agement, treatment protocols and to form the basis for STI
surveillance. In this paper we report the prevalence of
STIs/RTIs among pregnant women attending routine ante-
natal care in Moshi urban, Tanzania, as well as comparing
the occurrence of infections among HIV-seropositive and
sero-negative women. In addition, we compared the
results of this study with previous published data on the
prevalence of sexually transmitted infections among preg-
nant women in the same clinics.
To simplify the reading of the text, the acronym RTIs is
used exclusively and is to be understood to include STIs as
well as other non sexually transmitted diseases of the
reproductive tract (i.e. bacterial vaginosis and candidia-
sis).
Methods
Study sites and population
The study was conducted among pregnant women attend-
ing routine antenatal care at two of the largest primary
health care clinics (PHC) (Majengo and Pasua) in Moshi
urban district. The district is the capital of Kilimanjaro
region, situated in Northern Tanzania with the popula-
tion of about 230,000 people [19]. The two clinics are the
largest PHC and also represent women from the largest
geographical areas (administrative wards). Attendance for
antenatal care in this district is very high (> 97%) [19].
Eligibility criteria and recruitment procedures have been
described in detail elsewhere [20]. Briefly, from June 2002
to March 2004, a cohort of 2654 pregnant women, in
their third trimester, were invited to participate in a larger
project which aimed to describe the acceptability of HIV/
RTI perinatal interventions, especially prevention of
mother-to-child transmission of HIV at the PHC level as
well as to determine factors associated with incident HIV
and RTIs in the postpartum period. This was preceded by
a pilot project in 1999 which aimed primarily at deter-
mining the prevalence of RTIs among attendees, both
pregnant and non-pregnant, at primary health care clinics
in the same centres [18].
After obtaining informed consent, the participants under-
went counseling followed by a structured interview in
Swahili to collect information on socio-demographic var-
iables, sexual behavior, obstetric history, and on current
and past RTI symptoms. After the interview, a general and
gynecological examination was performed. Genital ulcers,
warts and abnormal vaginal or cervical discharge were
diagnosed clinically. Vaginal and cervical samples were
collected for diagnosis of various reproductive tract and
sexually transmitted infections. Venous blood was taken
for serological analysis of HIV, syphilis, HSV-2 and
Chlamydia trachomatis. Genital samples were not collected
from 99 of the women (4%) because they did not want to
undergo speculum examination. The same procedures as
above were followed in the pilot study in 1999.
Pregnant women with symptoms or signs suggestive of
RTIs were treated on the spot following the Tanzanian
Syndromic STI Case Management Guidelines. The women
were asked to return for their HIV/RTI results after one
week. Women found later, on laboratory testing, to have
untreated infections were treated for specific infections
during the follow-up visit. HIV positive women were
given a single dose of Nevirapine for prevention of
mother-to-child transmission (PMTCT) of HIV at post test
counseling and their infants were given Nevirapine syrup
within 72 hours after delivery. All of the women were
encouraged to inform their partners and to bring them for
counseling and testing. Those with proven RTIs were given
a contact card to give to their partners so that they could
come for treatment. All the services were free of charge for
both the women and their partners.
Approval for the study was obtained from the Tanzanian
Ministry of Health and The Regional Committee for Med-
ical Research Ethics; Region III (Regional komite for medi-
sinsk forskninsetikk region III)
Laboratory methods
Active syphilis was diagnosed by positive results of both
the rapid plasma regain test (RPR; Becton Dickinson, MD,
USA) and a specific test, Determine Syphilis TP (Abbott
Laboratories, IL, USA). HSV-2 was detected by the type-
specific HSV-2 ELISA test (Focus Diagnostics, Cypress,
California USA). HIV was diagnosed by a positive resultPage 2 of 8
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USA) and Capillus HIV 1/2 (Trinity Biotech, Ireland). Dis-
cordant results (< 1%) were resolved by an ELISA test,
Vironostika HIV Uni-form II (Organon Teknika, Boxtel,
Netherlands). IgG antibodies to Chlamydia trachomatis
was assessed in serum by an ELISA test (Ani Labsystems
Ltd, Finland).
Trichomoniasis was diagnosed using wet preparation,
candidiasis by visual inspection of Candida species on
potassium hydroxide (KOH) preparations or on Gram-
stained vaginal swabs. Bacterial vaginosis was diagnosed
on the basis of Amsel's criteria [20]. N gonorrhoeae was
diagnosed by culture (modified Thayer-Martin medium)
and/or positive Gram-stained of endocervical swabs for
Gram-negative diplococci.
Statistical analysis
The data were entered and analyzed using SPSS statistical
software, version 12.0 (SPSS, Chicago, IL, USA). Descrip-
tive statistics were obtained through frequencies and cross
tabulations. Comparison between groups was made using
the χ2 tests and Fisher exact test when appropriate. All
analyses were two-tailed and the level of significance was
set at 5%.
Results
The age of the 2654 participating women ranged from 14–
43 years (median 24 years), parity from 0–9 (median 1)
and gestation age from 28–40 weeks (median 30 weeks).
Other demographic details are described in Table 1.
The prevalence of laboratory diagnosed RTIs by HIV status
is shown in Table 2. Seven percent of the women had HIV
infection, 0.9% had active syphilis, 33.6% were HSV-2
positive and 17.5% had IgG antibodies for C trachomatis.
The prevalence of N gonorrhoeae was low (0.5%) while
23.9% of the women had trichomoniasis and/or bacterial
vaginosis.
Except for candidiasis, the prevalence of both viral and
bacterial RTIs were higher in HIV-seropositive women
than in the HIV-seronegative women, significantly for
syphilis (p < 0.001), HSV-2 (p = 0.03), gonorrhoea (p =
0.05), Chlamydia trachomatis Ab (p = 0.004), bacterial
vaginosis (p < 0.001) and genital ulcers (p = 0.002), Table
2.
Table 3 shows a comparison of RTI prevalence among
pregnant women with published work which was carried
out in 1999 at the same clinics as the current study [18]. A
significant decline in curable RTIs was observed, espe-
cially for syphilis (from 3.4% to 0.9%; p = 0.001), tricho-
moniasis (from 23.4% to 5.0%; p < 0.001) and bacterial
vaginosis (from 31.4% to 20.9%; p = 0.001). No signifi-
cant decrease was observed in the prevalence of HSV-2
infection.
Discussion
In this study viral infections (HSV-2 and HIV) are more
common than the curable non-viral STIs like trichomo-
niasis, syphilis or gonorrhoea [14,16,17]. We also noted a
decline of curable genital tract infections among pregnant
women between 1999 and 2004. A high prevalence of
HSV-2 and decreasing prevalence of curable genital tract
infections like syphilis, chlamydia, gonorrhoea, tricho-
moniasis and bacterial vaginosis has been reported in sev-
eral sub-Saharan countries among pregnant women
[15,22,23], among women in the general population
[23], and among women in high risk groups [16,17,23].
The introduction of and scaling up of syndromic
approach for management of STIs in most primary health
clinics may partly explain the decrease [6,23]. The change
in the genital infection spectrum however, highlights the
need to strengthen STI surveillance, so as to be able to
adjust syndromic management protocols according to the
epidemiological situation.
Despite the declining trend, the prevalence of trichomo-
niasis (5%) and bacterial vaginosis (20.9%) are still high,
considering that this was a pregnant population.
Untreated, trichomoniasis (TV) has been associated with
preterm birth and low birth weight (LBW), while bacterial
vaginosis (BV) can cause preterm rupture of membranes,
preterm birth, LBW and postpartum sepsis especially in
women with a previous history of preterm delivery [2].
Prematurity and low birth weight are among the leading
causes of perinatal morbidity and mortality in resource-
poor settings [1,2,10]. Studies have also indicated that
both BV and TV may increase the risk of HIV acquisition,
and BV may have an effect on mother-to-child transmis-
sion of HIV [10-12]. Efforts are thus required to treat these
vaginal infections in pregnancy. An approach like pre-
sumptive treatment (mass treatment on the presumption
that the disease might be present) has been associated
with significant reduction in the prevalence of these infec-
tions, and in the incidence of LBW, early neonatal death
and preterm delivery [4].
The active syphilis prevalence of 0.9% was similar to that
reported for women in the general population (0.2%) or
among bar workers (1.1%) in the same district [14,17].
However it was lower than in pregnant women in the
Mwanza (7.7%), Mbeya (4.1%) and Kagera (14.9%)
regions in Tanzania, and among pregnant women in
Uganda (3.3%), Zimbabwe (3.4%), Mozambique (4.7%)
and Cameroon (13%), showing variation within and
between countries in Africa [3-6,15,22,24]. Our results
however might be an underestimation in the prevalence
of syphilis because women with early foetal loss resultingPage 3 of 8
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women in the third trimester [3]. Lumbiganon et al
(2002) showed that even with a low background preva-
lence of 0.9%, women with syphilis had significantly
more adverse pregnancy outcomes e.g. LBW and perinatal
death [25]. Syphilis screening and treatment in pregnancy
is thus cost-effective even at prevalences < 1% and sup-
ports the WHO recommendation to perform serological
screening on all pregnant women at first visit [1]. With
resources being mobilized for expansion of prevention of
Table 1: Socio-demographic, behavioural and obstetric characteristics of the 2654 participating women in Moshi urban district, 
Tanzania
Variable N = 2654 % or range
Age of the women (mean, range) 24.61 14–43
Years of residence in Moshi (mean, range) 12.75 0–42
Marital status
Married 1624 61.2%
Cohabiting 790 29.8%
Single/divorced/separated 240 9.0%
Polygamous relationship 296 11.2%
Education
None 108 4.1%
Primary education 2275 85.6%
Secondary and above 271 10.3%
Formally employed 136 5.1%
Income per month
None 762 28.7%
< 30 USD 1726 65.0%
30 USD and above 166 6.3%
Obstetric history
Parity (Mean, range) 1.16 0–9
Gravidity (Mean, range) 2.35 1–10
Prior stillbirth/previous pregnancy 310/1686 18.4%
History of infant death/previous pregnancy 141/1686 8.4%
Age at first pregnancy (mean, range) 19.77 11–34
Sexual behavior characteristics
Age at fist debut (mean, range) 18.30 9–31
Report casual partners in past 12 months 117 4.4%
Lifetime sexual partners (mean, range) 1.61 1–7
Condom use at sexual debut 240 9.0%
Report of ever use of condoms 670 25.2%
Treatment for STI symptoms in past 12 months 685 25.8%Page 4 of 8
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sub-Saharan African countries, this opportunity should be
used to expand syphilis screening and treatment at the
same time.
The higher prevalence of STIs and bacterial vaginosis
among HIV-seropositive women than seronegative
women has also been reported among pregnant women
in Zimbabwe, Cameroon, Thailand and USA [5,8,24].
HIV-infected people have higher rates of genital infection
probably because of shared behavioral risk factors that
facilitate transmission of both infections [7], or increased
susceptibility to some RTIs like gonorrhoea and GUD,
especially with advanced immune suppression [26]. RTIs
in HIV-infected women has been associated with more
severe adverse reproductive health outcomes than in
uninfected women, including pelvic inflammatory dis-
ease, high grade cervical intraepithelial lesions, postpar-
tum endometrititis, preterm birth and neonatal death
[2,24,25]. Also, the presence of bacterial vaginosis, candi-
diasis, trichomoniasis, gonorrhoeae, chlamydia and HSV-
2 in HIV-infected women, increases HIV genital shedding,
thus an increased concentration of HIV in genital secre-
tions [9,10,28,29]. Increased infectiousness increases the
risk of both vertical and sexual HIV transmission. In fact,
studies have recently shown that bacterial vaginosis, cho-
rioamnionitis, genital ulcers and HSV-2 are associated
with increased rates of mother-to-child HIV transmission
[8,10,30,31]. Efforts to expand HIV-counseling and test-
ing services to all centers offering antenatal care is vital in
order to identify HIV-infected women. Apart from offer-
ing antiretroviral therapy (ART) to reduce perinatal HIV
Table 2: Prevalence of laboratory confirmed reproductive tract/sexually transmitted infections by HIV status among pregnant women 
in Moshi, Tanzania
N % HIV-positive HIV-negative
Serology
HIV-1 184/2654 6.9%
Active syphilis 23/2654 0.9% 3.3% 0.7% ***
HSV-2 427/1271 33.6% 43.2% 32.0% **
Chlamydia trachomatis 183/1048 17.5% 30.0% 16.6% **
Cervical & vaginal STIs/RTIs
Neisseria gonorrhoea 13/2555 0.5% 1.6% 0.4% *
Trichomonas vaginalis 129/2555 5.0% 7.1% 4.9%
Bacterial vaginosis 533/2555 20.9% 37.2% 19.6% ***
Candida albicans 292/2555 11.4% 14.2% 11.2%
Any vaginal infection¶ 754/2555 29.5% 46.4% 28.2% ***
Clinical STIs
Genital ulcer 41/2555 1.6% 4.4% 1.4% *
Genital warts 11/2555 0.4% 1.1% 0.4%
Any curable STI # 162/2558 6.3% 11.5% 5.9% **
Any curable STI/RTI † 633/2558 24.7% 43.2% 23.3% ***
¶ Trichomoniasis, bacterial vaginosis or candidiasis.
# Syphilis, gonorrhoea, trichomoniasis.
† Syphilis, gonorrhoea, trichomoniasis, bacterial vaginosis.
* p ≤ 0.05, ** p < 0.01, *** p < 0.001Page 5 of 8
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for genital tract infections. Treatment of genital infection
significantly lowers genital HIV concentrations
[9,10,28,29], thus treatment of maternal genital infec-
tions in HIV-infected women during pregnancy may sub-
stantially reduce negative reproductive effects on the
women themselves, may reduce sexual HIV transmission
and play a part in reducing mother-to-child transmission.
Efforts to address RTIs in HIV-infected women should not
be limited to pregnancy but should also be extended to
ART care clinics.
There may be possible limitations in the study regarding
some of the laboratory tests used to diagnose RTIs. Cul-
ture and microscopy were used to diagnose gonorrhoeae
and trichomoniasis in this study. Nucleic acid amplifica-
tion technology using polymerase chain reaction (PCR)
has been shown to have a higher sensitivity and specificity
than culture and microscopy for identification of both
gonorrhoea and trichomoniasis [32,33]. The traditional
tests used might have thus missed a substantial propor-
tion of these infections. Further, we used an IgG antibody
test to diagnose Chlamydia trachomatis. This test can only
show the proportion of women who had been exposed to
the Chlamydia infection in the past. It cannot differentiate
between women with active and with past infections.
Therefore it may be used only for epidemiological studies
and not for diagnosing women for treatment.
Despite the possible limitations, the study has demon-
strated that STIs and other reproductive tract infections are
still prevalent among pregnant women in the area. Rou-
tine screening and treatment during antenatal care is rec-
ommended. HIV-infected women should receive
adequate screening for genital tract infections during preg-
nancy. Future research and public health preventive
efforts should target not only the classical bacterial RTIs
but also HSV-2 as it was the most prevalent STI. Lastly,
studies using more sensitive assays (PCR) for screening
STIs during pregnancy are required, in order to give a
more precise picture of STI occurrence.
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